David A. Siegel Avanos Medical, Inc. Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 32,900 shares of AVNS stock, worth $374,731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,900
Previous 34,700
5.19%
Holding current value
$374,731
Previous $424,000
10.38%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AVNS
# of Institutions
302Shares Held
44.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY7.01MShares$79.9 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.71MShares$53.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$39 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.5MShares$28.5 Million0.44% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.35MShares$26.8 Million0.01% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $529M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...